UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050205
Receipt number R000057161
Scientific Title Verification of the Effect of Environment of "the Way of Tea" on the Body.
Date of disclosure of the study information 2023/01/31
Last modified on 2024/03/10 17:11:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of the Effect of Environment of "the Way of Tea" on the Body.

Acronym

Verification of the Effect of Environment of "the Way of Tea" on the Body.

Scientific Title

Verification of the Effect of Environment of "the Way of Tea" on the Body.

Scientific Title:Acronym

Verification of the Effect of Environment of "the Way of Tea" on the Body.

Region

Japan


Condition

Condition

Normal healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study examines the effects of "the Way of Tea" environment on the body based on physiological data of healthy men and women.

Basic objectives2

Others

Basic objectives -Others

.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Outcome Name: heart rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

For research subjects, clinical data are collected using medical equipment. We perform randomization as a crossover design.

Interventions/Control_2

.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

39 years-old >

Gender

Male and Female

Key inclusion criteria

This study targets healthy adults.

Key exclusion criteria

Those who are pregnant, Mental illness, Arrhythmia, Diabetes or autonomic nervous system disease.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name TOMOHIKO
Middle name
Last name NAKAMURA

Organization

Hamamatsu University Hospital

Division name

Neurology

Zip code

431-3125

Address

1-20-1, Handayama, Chuo-ku, Hamamatsu, Shizuoka

TEL

053-435-2111

Email

tomohiko@hama-med.ac.jp


Public contact

Name of contact person

1st name HISAE
Middle name
Last name MINAMI

Organization

Hamamatsu University School of Medicine

Division name

Neurology

Zip code

431-3125

Address

1-20-1, Handayama, Chuo-ku, Hamamatsu, Shizuoka

TEL

053-435-2111

Homepage URL


Email

h.minami.596@nitech.jp


Sponsor or person

Institute

Hamamatu University School of medicine

Institute

Department

Personal name



Funding Source

Organization

Hamamatu University School of medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee for Life Science and Medical Research, Hamamatsu University School of Medicine

Address

1-20-1, Handayama, Chuo-ku, Hamamatsu, Shizuoka

Tel

053-435-2111

Email

rinri@hama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 01 Month 28 Day

Date of IRB

2023 Year 01 Month 31 Day

Anticipated trial start date

2023 Year 02 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 01 Month 31 Day

Last modified on

2024 Year 03 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057161


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name